JNPC Pharma Innovation Limited
About JNPC Pharma Innovation Limited
Data last updated:
JNPC Pharma Innovation Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Ramky Pharma City (India) Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 23 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73100TG2011PLC077628.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Yancharla Rathnakara Nagaraja and Popuri Pandari Lal Krishna.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ramky Grandiose 15th Floor Sy No 136/2 & 4 Gachibowli, Hyderabad, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.6 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net profit of ₹1 Lakh (net margin 62.5%) and EBITDA of ₹1.4 Lakh (EBITDA margin 87.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRamky Grandiose 15th Floor Sy No 136/2 & 4 Gachibowli, Hyderabad, Telangana, India – 500032
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of JNPC Pharma Innovation Limited
JNPC Pharma Innovation has one previous CIN (Corporate Identification Number): U73100AP2011PLC077628. The current CIN is U73100TG2011PLC077628, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73100TG2011PLC077628 | Current |
| U73100AP2011PLC077628 | Previous |
Auditor Details of JNPC Pharma Innovation Limited
JNPC Pharma Innovation Limited is audited by Visweswararao & Associates for the financial year 2016.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Visweswararao & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of JNPC Pharma Innovation Limited
JNPC Pharma Innovation has 3 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yancharla Rathnakara Nagaraja Also directs: Ramky Infrastructure Limited, Mallannasagar Water Supply Limited, Maha Integrated Life Sciences City Limited and 5 more | Director | 03 Jul 2021 | 5 Years 3 Months | Current |
| Popuri Pandari Lal Krishna Also directs: Visakha Pharmacity Limited, Receps Limited, Eco Carbon Engineering Solutions Limited and 3 more | Director | 21 Jan 2013 | 13 Years 8 Months | Current |
| Pakanati Venkata Raghava Reddy Also directs: Eco Carbon Engineering Solutions Limited, Visakha Energy Limited, Visakha Pharma Innovation and Incubation Limited and 5 more | Director | 05 Feb 2024 | 2 Years 8 Months | Current |
Financials of JNPC Pharma Innovation Limited FY 2025 filings available
JNPC Pharma Innovation Limited reported revenue of ₹1.6 Lakh (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of JNPC Pharma Innovation Limited
Revenue fell 30% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of JNPC Pharma Innovation Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of JNPC Pharma Innovation Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 87.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 62.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of JNPC Pharma Innovation are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of JNPC Pharma Innovation Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of JNPC Pharma Innovation Limited
JNPC Pharma Innovation Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at JNPC Pharma Innovation Limited
Employment history and EPFO contributions of people linked to JNPC Pharma Innovation.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of JNPC Pharma Innovation Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for JNPC Pharma Innovation Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by JNPC Pharma Innovation Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of JNPC Pharma Innovation Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of JNPC Pharma Innovation Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on JNPC Pharma Innovation Limited
Frequently Asked Questions about JNPC Pharma Innovation Limited
JNPC Pharma Innovation is an active public limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 23 November 2011 (15+ years old) and is registered under CIN U73100TG2011PLC077628.
JNPC Pharma Innovation reported revenue of ₹1.6 Lakh for FY 2025 (down 30% YoY).
JNPC Pharma Innovation has 3 current directors:
- Yancharla Rathnakara Nagaraja - Director
- Popuri Pandari Lal Krishna - Director
- Pakanati Venkata Raghava Reddy - Director
JNPC Pharma Innovation reported a net profit of ₹1 Lakh (net margin 62.5%) and EBITDA of ₹1.4 Lakh (EBITDA margin 87.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of JNPC Pharma Innovation is 13% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 30%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of JNPC Pharma Innovation is U73100TG2011PLC077628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JNPC Pharma Innovation was incorporated on 23 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The registered office of JNPC Pharma Innovation is at Ramky Grandiose 15th Floor Sy No 1362 & 4 Gachibowli, Hyderabad, Telangana, India – 500032.
JNPC Pharma Innovation has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹15 Lakh.